||2breathe Technologies Ltd. pioneers the development of digital therapeutic devices for hypertension and sleeplessness. RESPeRATE: Hypertension Therapy is the world’s first FDA-cleared, non-drug, non-invasive hypertension treatment device. It’s used by hundreds of thousands of patients and is featured in the AHA statement on non-pharmacological treatments.
2breathe: Sleep Inducer, winner of a 2017 CES innovation award, was developed as RESPeRATE users reported dozing off during sessions. Turning the “side effect into a feature” we redesigned RESPeRATE device-guided-breathing technology into a smartphone powered consumer product to help the millions suffering from sleeplessness.
|Take a minute to prevent blindness!
There are over 400 million people with Diabetes worldwide. 1/3 of them develop Diabetic Retinopathy, the leading cause for blindness within working age adults.
Camereyes is developing a simple, end-to-end solution for detecting and monitoring Diabetic Retinopathy, at a push of a button, for places where professional ophthalmologists may be scarce or far away.
Leveraging cutting edge optics and advanced deep learning algorithms to provide high quality, fully automated online solution that requires no special setup or skill, making it ideal for primary care providers everywhere at any time.
|CNOGA Medical Ltd. is a privately held international company with headquarters in Israel and branch offices in China and Brazil. Cnoga Medical developed and distributes innovative Non-invasive medical devices for Diabetes and Cardiovascular disease management. We are the first company in the world that developed a line of Non-invasive and pain-free products that comply with the highest accuracy and quality standards. Using a camera real-time color image sensor and unique patent algorithm Cnoga medical manages to detect blood chromatic changes and analyze a vast amount of data as a function body physiology. This enables the capability to compute desired Bio Parameters in a non-invasive manner. Noninvasive products:
• TensorTip Combo Glucometer: the most accurate commercial non-invasive glucose measurement device for diabetic patients.
• TensorTip MTX/VSM: a compact innovative device that measures non-invasively 16 bio parameters in less than a minute.
The TensorTip MTX/VSM can measure cuff less blood pressure, Hemoglobin, Hematocrit, RBC, Pulse, Spo2, pH, Blood gas and Hemodynamic paramters. Cnoga devices are approved for marketing in more than 37 countries (Certifications: CE mark approved, CFDA, Anvisa, U.S FDA approved for Blood pressure & Pulse).
|DarioHealth Corp. (NASDAQ: DRIO) is a leading global digital health company serving tens of thousands of users with dynamic mobile health solutions. We believe people deserve the best tools to manage their treatment, and harnessing big data, we have developed a unique way for our users to analyze and personalize their diabetes management. With our smart diabetes solution, users have direct access to track and monitor all facets of diabetes, without having the disease slow them down. The acclaimed Dario™ Blood Glucose Monitoring System all-in-one blood glucose meter and native smartphone app gives users an unrivaled method for self-diabetes management. DarioHealth is headquartered in Caesarea.|
||DayTwo provides actionable health solutions based on gut microbiome research, utilizing the DayTwo microbiome Platform. We translate your unique gut microbiome into food recommendations personally tailored for maintaining balanced blood sugar levels. In addition to achieving better health through personalized nutrition and diet recommendations, we benefit people with diabetes and prediabetes, as well as those with other metabolic disorders. Our science is based on years of research led by Prof. Eran Segal and Dr. Eran Elinav from the world- renowned Weizmann Institute and exclusively licensed to DayTwo.|
||DreaMed Diabetes empowers insulin-dependent patients and their doctors with innovative and patient-centric decision support system.
ADVISOR Pro, a new evolution in diabetes tools, makes a complex sea of information easy to use and act on. The continuously learning cloud-based platform constantly analyzes all available data, turning pure information into actionable insights so you can quickly adapt your treatment choices to life's ever-changing variables.
DreaMed's multidisciplinary team includes thought-leading endocrinologists and engineers: founder and Chief Science Officer Professor Moshe Philip; founder and CEO Eran Atlas; founder and Chief Medical R&D Officer Dr. Revital Nimri; Chief Product Officer Eran Agmon; and others.
||Eco-Fusion is a digital therapy company offering a flexible mobile platform that addresses a variety of chronic illnesses. The company's initial focus is diabetes management. Its patent pending stress reducing technology, Serenita, was shown to reduce A1c levels of Type II diabetics with high blood sugar by 18% within 8 weeks. The company's platform NewMe is a mobile and web platform that connects patients and caregivers, allowing medical professionals to deliver, monitor, and adjust treatment. The system provides a picture of the patient's health that includes medical records, biometric real-time data, and daily health-related activity. NewMe Diabetes is geared toward Type I, Type II, and gestational diabetes.|
|Just breath! Non-invasive breath decoder for blood glucose metering.
Cutting-edge technology that observes the indicator gases in breath with
unprecedented sensitivity, in real-time, in reasonable size and cost for personal and institutional use. Israel, USA, India. Our team Includes inventors with international experience and achievement based recognition in detecting hundreds of gases in high and low complexity level (ppt & ppb sensitivity). Absolute measurement in several seconds, non-invasive small device for personal use along with clinic’s high performance instrument for multiple compounds simultaneously. eXscopia, making the life of diabetics effortless and simple.
|GlucoMe is a comprehensive digital diabetes care platform that consists of a Smart Glucose Monitor, Insulin Pen Monitor, Mobile App and cloud-based Digital Diabetes Clinic. Glucose measurements and insulin intake are automatically recorded by each patient’s smartphone, and analyzed in the cloud. GlucoMe’s personalized reports, real-time alerts and proactive treatment approach help medical professionals and patients ensure compliance, optimize diabetes management, improve HbA1c levels, and impact overall quality of life. GlucoMe’s Digital Diabetes Clinic integrates with EHR and continuously analyzes clinical data, providing treatment recommendations for each patient. Along with population management, GlucoMe enables digital or face-to-face intervention for the right patients at the right time.
|GluSense is developing Glyde (TM) CGM, a miniature, long term implantable continuous glucose sensor. The sensor is designed for operation of a full year and relies on modified live cells for continuous replenishment of the fluorescent biosensing protein used for glucose detection. The optical measurement is performed by the combined functionality of the implant and an external wearable device. Glucose data is uploaded from the wearable device to a mobile app and then to cloud. GluSense is located in Rehovot Science Park and is part of the Rainbow Medical group.
||HeartBeat Technologies (HBT) has developed proprietary software that enables doctors, nurses and individuals to monitor heart related parameters and provide non-invasive care management. HBT's solution provides actionable tools that are reliable and user friendly to help prevent hospitalization and re-admissions by remotely monitoring patients. The parameters monitored are heart rate, oxygen levels, continuous blood pressure, cardiac output, stress, hydration and other cardiovascular parameters when paired with off-the-shelf Pulse Oximeter or a wearable device such as the Polar M600.|
HelpAround @ Spot32
PO Box 12627
Telephone: +1 (646) 798-9555
|At helparound, we believe that families facing life-changing diagnoses, such as CF, Kidney Disease and HIV, deserve better than today’s generic, brochure-like Patient Support Programs. Our patented platform extends patient-hubs’ CRMs to mobile, to streamline and personalize their services based on each individual’s real-life behaviors.|
||iFeel develops the first autonomic nervous system (ANS) digital therapy to monitor and supplement traditional treatments for stress, hypertension, diabetes and pulmonary diseases. iFeel’s fun mobile games optimize the way patients breathe, balancing their autonomic nervous system and improving cardiovascular and pulmonary functions. The iFeel solution combines the science of Heart Rate Variability (HRV) respiratory biofeedback training, medical-grade heart rate PPG sensors, and a patent-pending algorithm to predict and treat chronic diseases.|
||Magicalfa had developed a Neuro Modulation wearable device addressing multiple indications including high blood pressure, sleeping, ADHD and Parkinson. The device has CE mark as a wellness device and is undergoing multiple clinical studies.|
||Neura is a technology company that uses Artificial Intelligence (AI) to enable mobile apps and Internet of Things (IoT) product companies to personalize and adapt to their customers’ preferences and needs by reaching them at precise, meaningful moments throughout their day. The result is increased engagement and reduced churn. The Neura AI platform utilizes its sophisticated hybrid AI engine, its mobile SDK, and a library of API calls to bring physical world intelligence into today’s most innovative apps and IoT products.|
||New Beginning is a Digital Health - Wellness Innovation Agency. New Beginning is a pioneer in the field of Innovation management, strategy, execution and brand building for the digital health and wellness industries since 2013.
Our mission is to improve the lives of millions of people worldwide. We aim to transform and improve the healthcare market and reduce budgets through innovative consumer-health solutions, services, technologies and business models.
We operate in the Health IT fields of Telemedicine, iOT, Medical Devices, Wearable Sensors Devices, Mobile Applications, Diagnostics and Monitoring, Point-of-Care (POC), Emergency Intervention, Electronic Medical Record (EMR), Chronic Disease Management, Health System Management Platform.
Those solutions are for home use and professional environment managed by hospital, HMOs, clinics, physician's offices and other institutional entities.
Our team brings extensive experience from multiple backgrounds including consumer goods, lifestyle and technology to the healthcare industry. This allows us to provide an end-to-end solution from ideation to execution, product development to commercialization.
New Beginning is active in identifying and sourcing cutting edge technology solutions for health industry leaders, medical devices, pharmaceutical companies and investors. We can help you facilitate and manage your partnership and investment in the startup nation.
We innovate as entrepreneurs, we operate as startups and we execute as industry leaders to deliver exceptional results
||Nutrino is a leading provider of nutrition related data services, analytics, and technologies. The company is building the world’s largest and most adaptable nutrition insights platform.
The Nutrino approach recognizes that not only will two people respond differently to the same food, but a single individual may respond differently to the same food at different times. These unique, contextual insights allow Nutrino to define an individual’s FoodPrint™: the digital signature of how food affects the body. Understanding a person’s FoodPrint gives greater control in using nutrition as a means to combat chronic disease, manage weight, and improve wellbeing.
||Oxitone developed and market the world’s first FDA-cleared Wrist-Sensor Blood Oxygen Monitor without a bulky fingertip probe to meet the basic healthcare needs: keeping people healthier at home by providing hospital grade digital continuous care.
Oxitone offer a wearable Pulse Oximeter (smartwatch/ bracelet ) that enable the patient to wear it 24/7 (unlike fingertip device) and to measure continuously . We are measuring every second and can detect changes and trends.
Once we detect change we can send automatic alarm to call center , physician , family member and care giver.
The bracelet communicate via Bluetooth with smartphone app and through the smartphone to the cloud. All patients data aggregated on the cloud
Oxitone received both FDA and CE approvals
Continuous blood oxygen, pulse, activity and sleep apnea
Symptoms and supplemental O2 tracking, synched with Care Plan
24/7 automated digital managed care, predictive analytics and smart alerts
||Physio-Logic provides accelerated medical device approval, certification and regulatory compliance solutions. It is Israel’s leading vendor with the largest multidisciplinary team of seasoned professionals covering all aspects of medical device approval (Registration, Quality, Clinical Trials) in key markets (North America, the EU, Far East, Middle East). Physio-Logic’s digital health team masters all aspects of digital health regulation including software quality, privacy, security and international registration.|
||Plate my Meal developed world’s most simple concept to healthy eating!
Backed by clinical trials proving it has significant impact on children’s eating habits and endorsed by Ministries of Health!
Addressing healthy eating 3 major dilemmas with simple & applicable answers:
WHEN to eat – 5 designated plates for 5 meals and snacks a day
WHAT to eat – Choose from a variety of foods and food groups suggested on each plate
HOW MUCH to eat – Portion control by compartment size
Plate my Meal’s edge:
• Backed by academic research proving Plate my Meal has significant impact on children’s eating habits – Decreasing food intake and increasing vegetables and protein intake.
• IP protected
• Endorsed by Ministries of Health
Contact person: Udi Goori,
Chief Product Officer
|RMDY Health (formerly Wellness Layers) offers a cloud platform that enables healthcare stakeholders to quickly and easily create their own white-label Digital Therapeutics, Population Health and Healthcare CRM services. Clients include Medtronic, IBM, AHA and others.|
Vaica Medical Ltd
Company number: 514004852
Address : 7 Beit Hilel street, Tel Aviv
Contact person: Nir Tobis
|Vaica was established in 2007 to provide medication adherence customized solutions.
Vaica provides medication adherence customized solutions for healthcare organizations in order to address the wide spread phenomena of medication non-compliance.
At the core of our solutions is a cloud-based software, enabling the remote deployment, management & monitoring of smart medication dispensers and vital sign monitors.
Vaica’s mission is to improve the life quality of chronically-ill patients and allow them to live longer at home independently.
VOTIS Subdermal Imaging Technologies, Ltd.
Dostai Street 3/2, Jerusalem 93181, Israel
Corporate Contact: Merrill Weber, Co-Founder, CEO, and President
|VOTIS Subdermal Imaging Technologies helps diabetics keep their feet. We screen for peripheral vascular disease and infection, and help the healthcare provider to diagnose and monitor their scope and severity. We gather information entirely non-invasively, and transmit the captured information via the cloud to remote servers for analysis and classification according to objective standardized criteria. We automatically create a dynamic 3D model of tissue and arteries within the foot. The processed information is transmitted into the patient’s electronic medical records. Access to this information can significantly reduce amputation rates by enabling healthcare providers to utilizing a range of less-drastic treatment options that may not be available if the disease progresses.|
||Well-Beat is a next-generation chronic patients’ behavioral change system through personalized interventions. Customizing patient interventions is based on integration between behavioral sciences and proprietary data-driven technology.
Well-Beat enables pharmaceutical companies & Hubs to dramatically increase treatment regime adherence in chronic patients, both through direct digital interventions and through therapist empowerment via the Well-Beats' utility.
As a result, Well-Beat decreases pharmaceutical companies’ annual losses due to medication non-adherence (546$) and creates significant advantage and differentiation.